Your search returned 5 results.

Results
	1.	Pertuzumab for the treatment of breast cancer: a safety review. [Review] MedStar authors: Swain, Sandra M PMID: 26982349 Year: 2016 Citation: Expert Opinion on Drug Safety. 15(6):853-63, 2016 Jun Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Gao J, Swain SM DOI: https://dx.doi.org/10.1517/14740338.2016.1167185 Add to cart (remove)
	2.	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 23868905 Year: 2013 Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdt274 Add to cart (remove)
	3.	Avastin withdrawal symptoms. MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 22263961 Citation: Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Editorial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.1517/14656566.2012.652088 Add to cart (remove)
	4.	Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors: Priebat, Dennis A PMID: 28988646 Year: 2017 Citation: Lancet Oncology. 18(11):1493-1501, 2017 Nov Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II DOI: https://dx.doi.org/10.1016/S1470-2045(17)30624-1 Add to cart (remove)
	5.	Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors: Swain, Sandra M PMID: 34890214 Year: 2022 Citation: Journal of Clinical Oncology. 40(5):438-448, 2022 02 10. Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP DOI: https://dx.doi.org/10.1200/JCO.21.00896 Add to cart (remove)

Powered by Koha